Careers Investors Sustainability Contact Vlog EN TECHNOLOGIES APPLICATIONS RESOURCES SHOP COMPANY Repligen responds to COVID-19: Operations Status About Repligen Our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide. Focused on cost and process efficiencies, we deliver innovative technologies and solutions that help set new standards in bioprocessing. ADVANCING BIOPROCESSING Repligen is a bioprocessing-focused life sciences company bringing expertise and innovation to our customers since 1981. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs. Technology leader In perfusion, pre-packed columns, integrated systems for tangential flow filtration (TFF) First to market With high-impact products for cell culture intensification, tangential flow depth filtration, pre-packed columns, single-use cassettes, integrated TFF systems Fastest growing Bioprocessing tools provider, fueled by innovative product development and strategic acquisitions Our business is influenced by the growth in demand for biologic drugs, particularly the global market for monoclonal antibodies (mAbs). Demand for our products is associated with the overall volume of mAbs manufactured; there is little connection to final drug pricing or the clinical or commercial success or failure of an individual biologic drug. As the number of biologic drugs on the market and in development continues to increase, and as worldwide access to biologics expands with the emergence of biosimilar and bio-better versions of original drugs, biopharmaceutical manufacturers are tasked with reducing the time and cost associated with production while improving yield and retaining the highest levels of product quality. These market dynamics are driving process intensification and adoption of disposable technologies and other products that offer convenience, flexibility and the ability to improve capacity utilization in the most modern continuous processing facilities as well as in standard batch processing facilities. The bioprocessing products manufactured by Repligen are designed to address these important needs of biopharmaceutical manufacturers in an increasingly competitive environment. Repligen develops and manufactures products for the biopharmaceutical industry under an ISO 9001 quality management system. We focus on the timely delivery of high quality, consistent and robust products, to ensure business continuity for our customers. ABOUT REPLIGEN MANUFACTURING Repligen is headquartered in Boston, Massachusetts with major manufacturing sites in Massachusetts, California, Sweden, and Germany. Products are marketed globally through a direct commercial organization in the United States, Europe and Asia, as well as through strategic partners and distributors in select markets. CONTACT REPLIGEN © Copyright 2021 Repligen Corporation. All rights reserved. Contact Privacy Policy Legal Careers Cookie Control Your choice regarding cookies on this site We use cookies to optimize site functionality and give you the best possible experience. I AcceptI Do Not AcceptSettings HOME TECHNOLOGIES APPLICATIONS RESOURCES SHOP COMPANY ACCOUNT CAREERS INVESTORS SUSTAINABILITY CONTACT VLOG SIGN IN PROFILE SIGN OUT SELECT LANGUAGE